about
Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channelRoscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanismSTIM1L traps and gates Orai1 channels without remodeling the cortical ERTransient receptor potential canonical channels are required for in vitro endothelial tube formation.Activation of transient receptor potential canonical 3 (TRPC3)-mediated Ca2+ entry by A1 adenosine receptor in cardiomyocytes disturbs atrioventricular conductionTransient Receptor Potential Canonical (TRPC)/Orai1-dependent Store-operated Ca2+ Channels: NEW TARGETS OF ALDOSTERONE IN CARDIOMYOCYTES.Evidence for the involvement of type I interferon in pulmonary arterial hypertension.Chemotherapy-induced pulmonary hypertension: role of alkylating agents.Potassium channels in pulmonary arterial hypertension.T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension.CFTR and Ca Signaling in Cystic Fibrosis.SERCA and PMCA pumps contribute to the deregulation of Ca2+ homeostasis in human CF epithelial cells.TRPC1 and TRPC4 channels functionally interact with STIM1L to promote myogenesis and maintain fast repetitive Ca2+ release in human myotubes.Use of β-Blockers in Pulmonary Hypertension.Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.Guanabenz, an alpha2-selective adrenergic agonist, activates Ca2+-dependent chloride currents in cystic fibrosis human airway epithelial cells.Calcium homeostasis is abnormal in cystic fibrosis airway epithelial cells but is normalized after rescue of F508del-CFTR.Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells.Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension.During post-natal human myogenesis, normal myotube size requires TRPC1- and TRPC4-mediated Ca²⁺ entry.Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.A functional tandem between transient receptor potential canonical channels 6 and calcium-dependent chloride channels in human epithelial cells.Inositol 1,4,5 trisphosphate receptor 1 is a key player of human myoblast differentiation.Calumenin contributes to ER-Ca2+ homeostasis in bronchial epithelial cells expressing WT and F508del mutated CFTR and to F508del-CFTR retention.Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.KCNK3: new gene target for pulmonary hypertension?Ca2+ handling remodeling and STIM1L/Orai1/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy.NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.Corrigendum to "A Simple Method to Assess In Vivo Proliferation in Lung Vasculature with EdU: The Case of MMC-Induced PVOD in Rat".Endothelial-to-mesenchymal transition in pulmonary hypertension.Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model”Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary HypertensionmiR-223 reverses experimental pulmonary arterial hypertensionFunctional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertensionBmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension
P50
Q28567125-604F76E3-D209-4D5E-BAF4-C97B3659732CQ34954019-3CC529CA-CA2C-4514-9FCE-9F785BCD282CQ35522552-C01FD4F5-E82D-4612-B778-8A7C1CDE3AC6Q35774121-22EA77E9-D983-42DF-9AA7-A7A814F8FCDCQ36137368-2048A15F-F6BF-48AE-B397-F0A501E110AFQ37065951-334765D3-3277-4588-BD27-24A3362DE82EQ37735087-E2B73F9D-73DF-4817-BEAF-C26A7500015BQ38286586-4DC8EA32-40C1-4F0C-9770-0356622ADC43Q38581241-D8259161-77C2-48BE-BFFD-AD29DF4EC1B2Q38706299-024EFE67-DA0E-496C-ACE8-BBDFC15CE67DQ38811524-53B1DE3A-D210-44A8-BE92-A13479A95AB2Q38911955-F0D3C52B-1C62-4A97-9235-0A6E0C971CA1Q38968065-CCEFD2BD-F3A4-4B46-B921-09306C459F53Q39212213-5F3CD821-71CE-4F22-B73B-059BAC284F0DQ39732202-3A0109EA-57B7-4DEA-80AC-3F6A535D96F5Q39923304-80CE5CBB-2C15-4724-849A-003647DBD417Q39959384-13AD5E2C-0C60-46B9-BAE7-B1D3049434A4Q40115646-941855B4-9325-46D1-9BDE-58E32CDD25EBQ40286904-AA44EF33-603C-4948-8E8B-3E7EE578A37DQ41593009-09459EDC-3F56-4E5F-982D-B06F0723E427Q45282418-E5E22911-51FD-483A-8F51-A124C589928FQ47434868-6A39FB3E-0830-409B-8D97-5D9A181605B8Q47649958-838F509A-8CA2-45F9-9C97-E028234F513DQ48331371-D3381DA8-263A-46C3-A17C-329149F27CDCQ50438466-1DCDC721-DC92-4EC9-87C1-EBAEE1128CE8Q51028508-3C5AE63F-B597-4274-953F-393F081A0F6AQ51141153-993C93CC-D0AE-4F9C-9B1E-8EE93C4D528BQ51283435-65833A9C-8264-45CD-8264-D5B582913EB3Q51729363-3D9563DE-1C71-4989-B7A5-CD9D11ACA03DQ52596353-3FD494D0-4385-4A5F-8614-E30943146714Q52688448-A9CCB1FD-B9EF-44FE-AA44-1D80F86166E1Q52883264-F5F0EDB9-AC44-4F19-8115-EBB91D16836BQ53459929-ACE95AFE-817B-4324-AB2B-A24C2B8AF242Q55068646-11073980-BB86-4606-990B-595A17862F49Q57466982-3276BC2B-4320-49E9-BB9B-FFC45E8BC34BQ61818914-D265A6D5-39B5-4E44-B53F-D12A77D7AC94Q61894856-DDA6F792-A2A3-41C2-8A34-62836A10B482Q85397195-94CC53EF-5793-45C2-BF38-FB3E5CD76098Q90447038-A39FB8ED-DC6F-439F-8E16-6CB653E4D7EBQ90759548-1C72D580-1910-47FC-A473-F893507C71AB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabrice Antigny
@ast
Fabrice Antigny
@en
Fabrice Antigny
@es
Fabrice Antigny
@nl
type
label
Fabrice Antigny
@ast
Fabrice Antigny
@en
Fabrice Antigny
@es
Fabrice Antigny
@nl
prefLabel
Fabrice Antigny
@ast
Fabrice Antigny
@en
Fabrice Antigny
@es
Fabrice Antigny
@nl
P106
P31
P496
0000-0002-9515-6571